The latest price target for PROCEPT BioRobotics (NASDAQ:PRCT) was reported by Wells Fargo on December 3, 2024. The analyst firm set a price target for $112.00 expecting PRCT to rise to within 12 months (a possible 38.34% upside). 16 analyst firms have reported ratings in the last year.

The latest analyst rating for PROCEPT BioRobotics (NASDAQ:PRCT) was provided by Wells Fargo, and PROCEPT BioRobotics their overweight rating.

There is no last upgrade for PROCEPT BioRobotics

There is no last downgrade for PROCEPT BioRobotics.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of PROCEPT BioRobotics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for PROCEPT BioRobotics was filed on December 3, 2024 so you should expect the next rating to be made available sometime around December 3, 2025.

While ratings are subjective and will change, the latest PROCEPT BioRobotics (PRCT) rating was a with a price target of $0.00 to $112.00. The current price PROCEPT BioRobotics (PRCT) is trading at is $80.96, which is within the analyst’s predicted range.